TS/A: Difference between revisions
Appearance
Content deleted Content added
No edit summary |
Added link to Cellosaurus |
||
Line 5: | Line 5: | ||
==References== |
==References== |
||
{{Reflist}} |
{{Reflist}} |
||
==External links== |
|||
*[https://web.expasy.org/cellosaurus/CVCL_F736 Cellosaurus entry for TS/A] |
|||
[[Category:Rodent cell lines]] |
[[Category:Rodent cell lines]] |
Revision as of 22:48, 13 March 2018
TS/A is a mouse mammary adenocarcinoma cell line established in the early 1980s from a spontaneous tumor of a retired breeder BALB/c female mouse.[1] In the 1990s it was widely used as a recipient cell line for the transduction of cytokine genes and other genes of immunological interest, to produce recombinant experimental vaccines that induced anti-tumor immunological responses.[2]
References
- ^ Nanni P, C De Giovanni, P-L Lollini, G Nicoletti, and G Prodi. 1983. "TS/A: a new metastasizing cell line from a BALB/c spontaneous mammary adenocarcinoma". Clinical and Experimental Metastasis. 1(4): 373-80.
- ^ Allione A, M Consalvo, P Nanni, P-L Lollini, F Cavallo, M Giovarelli, M Forni, A Gulino, MP Colombo, P Dellabona, H Hock, T Blankenstein, FM Rosenthal, B Gansbacher, MC Bosco, T Musso, L Gusella, and Guido Forni. 1994. "Immunizing and curative potential of replicating and nonreplicating murine mammary adenocarcinoma cells engineered with interleukin (IL)-2, IL-4, IL-6, IL-7, IL-10, tumor necrosis factor alpha, granulocyte-macrophage colony-stimulating factor, and gamma-interferon gene or admixed with conventional adjuvants". Cancer Research. 54(23): 6022-6026.